載入...
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation
Repositioning of approved drugs for identifying new therapeutic purposes is an alternative, time and cost saving strategy to classical drug development. Here, we screened a library of 786 FDA-approved drugs to find compounds, which can potentially be repurposed for treatment of T cell-mediated autoi...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821167/ https://ncbi.nlm.nih.gov/pubmed/33488629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.616570 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|